These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 14557175)

  • 41. Carcinoembryonic antigen cell adhesion molecule-1 (CEACAM1) in posterior uveal melanoma: correlation with clinical and histological survival markers.
    Khatib N; Pe'er J; Ortenberg R; Schachter J; Frenkel S; Markel G; Amer R
    Invest Ophthalmol Vis Sci; 2011 Dec; 52(13):9368-72. PubMed ID: 22039239
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Iodine brachytherapy as an alternative to enucleation for large uveal melanomas.
    Puusaari I; Heikkonen J; Summanen P; Tarkkanen A; Kivelä T
    Ophthalmology; 2003 Nov; 110(11):2223-34. PubMed ID: 14597534
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Diagnosis of uveal melanoma. Contribution of echography and the 32P test].
    Bosco F; Grignolo FM; Lo Presti L; Simone F; Perla C
    Recenti Prog Med; 1984 Jan; 75(1):66-91. PubMed ID: 6718804
    [No Abstract]   [Full Text] [Related]  

  • 44. Local recurrence after uveal melanoma proton beam therapy: recurrence types and prognostic consequences.
    Caujolle JP; Paoli V; Chamorey E; Maschi C; Baillif S; Herault J; Gastaud P; Hannoun-Levi JM
    Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1218-24. PubMed ID: 23177670
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cytogenetics of uveal melanoma: a 7-year clinical experience.
    Damato B; Duke C; Coupland SE; Hiscott P; Smith PA; Campbell I; Douglas A; Howard P
    Ophthalmology; 2007 Oct; 114(10):1925-31. PubMed ID: 17719643
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prognostic factors following enucleation of 111 uveal melanomas.
    Coleman K; Baak JP; Van Diest P; Mullaney J; Farrell M; Fenton M
    Br J Ophthalmol; 1993 Nov; 77(11):688-92. PubMed ID: 8280680
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sex Disparity in Survival of Patients With Uveal Melanoma: Better Survival Rates in Women Than in Men in South Korea.
    Park SJ; Oh CM; Yeon B; Cho H; Park KH
    Invest Ophthalmol Vis Sci; 2017 Mar; 58(3):1909-1915. PubMed ID: 28362882
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intravascular presence of tumor cells as prognostic parameter in uveal melanoma: a 35-year survey.
    Ly LV; Odish OF; Wolff-Rouendaal Dd; Missotten GS; Luyten GP; Jager MJ
    Invest Ophthalmol Vis Sci; 2010 Feb; 51(2):658-65. PubMed ID: 19797220
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Effect of X-ray irradiation of the orbit after enucleation in patients with uveal melanoma].
    Omulecki W; Swietliczko I
    Klin Oczna; 1991; 93(2-3):76-7. PubMed ID: 1870301
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Enucleations in uveal melanoma (analysis of archival records)].
    Grishina EE; Davydov DV; Stoiukhina AS
    Vestn Oftalmol; 2010; 126(2):30-4. PubMed ID: 21105376
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Uveal melanoma: management and outcome of patients with extraocular spread.
    Bellmann C; Lumbroso-Le Rouic L; Levy C; Plancher C; Dendale R; Sastre-Garau X; Asselain B; Desjardins L
    Br J Ophthalmol; 2010 May; 94(5):569-74. PubMed ID: 19965816
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Association of ocular and oculodermal melanocytosis with the rate of uveal melanoma metastasis: analysis of 7872 consecutive eyes.
    Shields CL; Kaliki S; Livesey M; Walker B; Garoon R; Bucci M; Feinstein E; Pesch A; Gonzalez C; Lally SE; Mashayekhi A; Shields JA
    JAMA Ophthalmol; 2013 Aug; 131(8):993-1003. PubMed ID: 23681424
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Retrospective study of uveal melanoma].
    Tóth J
    Magy Onkol; 2005; 49(1):19-25. PubMed ID: 15902329
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prognostic value of S-100-beta serum concentration in patients with uveal melanoma.
    Missotten GS; Tang NE; Korse CM; Hurks HM; de Wolff-Rouendaal D; Keunen JE; Jager MJ; Bonfrer JM
    Arch Ophthalmol; 2003 Aug; 121(8):1117-9. PubMed ID: 12912688
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of heterogeneous distribution of monosomy 3 on prognosis in uveal melanoma.
    Bronkhorst IH; Maat W; Jordanova ES; Kroes WG; Schalij-Delfos NE; Luyten GP; Jager MJ
    Arch Pathol Lab Med; 2011 Aug; 135(8):1042-7. PubMed ID: 21809997
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tumor-infiltrating macrophages (CD68(+) cells) and prognosis in malignant uveal melanoma.
    Mäkitie T; Summanen P; Tarkkanen A; Kivelä T
    Invest Ophthalmol Vis Sci; 2001 Jun; 42(7):1414-21. PubMed ID: 11381040
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Correlation of in vitro 32P counts with histologic features of malignant melanoma of choroid and ciliary body.
    Rao NA; Gamel JW; McMahon RT; McLean IW
    Invest Ophthalmol Vis Sci; 1977 Jan; 16(1):98-102. PubMed ID: 832971
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prognostic accuracy of the mean of the largest nucleoli, vascular patterns, and PC-10 in posterior uveal melanoma.
    Seregard S; Spångberg B; Juul C; Oskarsson M
    Ophthalmology; 1998 Mar; 105(3):485-91. PubMed ID: 9499780
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Detection of M2-macrophages in uveal melanoma and relation with survival.
    Bronkhorst IH; Ly LV; Jordanova ES; Vrolijk J; Versluis M; Luyten GP; Jager MJ
    Invest Ophthalmol Vis Sci; 2011 Feb; 52(2):643-50. PubMed ID: 20811059
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical and histopathological features of choroidal melanoma-related enucleated eyes in a Spanish tertiary hospital.
    García Tirado A; Asencio Durán M; Berjón A; Ruiz Bravo-Burguillos E; Peralta Calvo J
    Arch Soc Esp Oftalmol (Engl Ed); 2019 May; 94(5):225-231. PubMed ID: 30904338
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.